VCR has halved in value since last XMAS and the SP represents great value. Summary of announcements that have not been factored into the current SP are;
1. US trials for BTT and DT have started (will be paid about $100,000/unit during US trials);
2. almost 150 implants to date;
3. $48million in cash reserves as of Jun 30, 07;
4. TGA approval, means they can sell the VentrAssist in Aust$$$
5. Already have approval to sell in Europe$$$;
6. Thoratec will find out if they have FDA approval for BTT in Nov, 07 (this will surely open up market);
7. Steady inrease in implants and centres worldwide will see Ventracor become a powerful player in the market!
8. SP has come down from $1.20 back in Jan,07 to 63c today.
- None of the above has been factored into the SP, which IMO rates it a STRONG BUY RATING!
- Forums
- ASX - By Stock
- VCR
- undervalued
VCR
ventracor limited
undervalued
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VCR (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online